Study shows the potential of experimental monoclonal antibodies to treat Epstein-Barr virus infection

By | October 28, 2022
A panel of investigational monoclonal antibodies (mAbs) targeting different sites of the Epstein-Barr virus (EBV) blocked infection when tested in human cells in a laboratory setting.